News
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...
6h
MedPage Today on MSNHealth App Boosts 'Self Efficacy' in Patients With SpondyloarthritisBARCELONA -- A smartphone app called Axia designed to encourage people with axial spondyloarthritis (axSpA) to exercise ...
STORY: Eli Lilly said Monday it will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying ...
Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...
Eli Lilly already has a couple of top GLP-1 drugs that help patients with diabetes (Mounjaro) and weight loss (Zepbound), but ...
Explore more
Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...
Eli Lilly is reducing the price of the highest doses of its popular drug Zepbound for folks who aren't using insurance.
Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.
3h
MarketBeat on MSNCould Meta and Eli Lilly Trigger the Next Stock Split Boom?While stock splits are far from easy to predict, two names stand out for their potential to do so going forward. Those stocks ...
Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...
The company said the 12.5 milligrams and 15 mg doses of the drug will be available for US$499 per month on the website with shipments to self-paying patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results